Myriad Genetics Inc (NASDAQ:MYGN)
| 23.42 Delayed Data As of Jun 02 |  +0.32 / +1.39%Today’s Change | 13.92 Today|||52-Week Range 28.18 | +61.41% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 64.1M | 68.5M | 102.4M | 110.9M | |
| Short Term Investment Cash | -700.0K | 4.4M | 33.9M | 8.5M | ||
| Cash & Short Term Investments | 144.8M | 159.0M | 150.7M | 180.6M | ||
| Receivables | Receivables | 87.7M | 95.0M | 111.3M | 102.1M | |
| Inventories | Inventories | 25.1M | 38.3M | 42.2M | 34.3M | |
| Current Assets | Prepaid Expenses | 12.5M | 22.2M | 12.9M | 9.4M | |
| Other Current Assets | 13.5M | 0.00 | -- | -- | ||
| Current Assets | 283.6M | 314.5M | 317.1M | 326.4M | ||
| Total Assets | Property, Plant and Equipment - Gross | 138.1M | 141.7M | 148.4M | 157.1M | |
| Depreciation | -70.9M | -83.4M | -97.3M | -113.9M | ||
| Intangible Assets | 369.8M | 422.8M | 807.7M | 773.8M | ||
| Other Assets | 369.8M | 427.8M | 807.7M | 773.8M | ||
| Total Assets | 766.2M | 943.7M | 1.3B | 1.2B | ||
| Liabilities | Accounts Payable | 21.1M | 21.1M | 22.0M | 26.0M | |
| Accrued Expenses | 8.5M | 9.4M | 14.1M | 14.5M | ||
| Other Current Liabilities | 13.8M | 13.9M | 144.0M | 22.4M | ||
| Other Liabilities | 68.7M | 72.3M | 217.5M | 102.2M | ||
| Total Liabilities | Long Term Debt | 0.00 | 0.00 | 99.1M | 9.3M | |
| Deferred Taxes | -200.0K | -17.9M | -84.4M | -57.3M | ||
| Other Liabilities | 3.9M | 12.3M | 1.3M | 300.0K | ||
| Total Liabilities | 104.1M | 195.6M | 539.9M | 261.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | -200.0K | -200.0K | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 662.1M | 748.1M | 778.2M | 964.9M | ||
| Total Shareholder Equity | 662.1M | 748.1M | 778.2M | 964.9M | ||
| Share Information | Common Shares Outstanding | 68.9M | 69.1M | 68.4M | 70.6M | |
| Addtl. Info. | No data currently available for this section. | |||||
